Code of Federal Regulations: Containing a Codification of Documents of General Applicability and Future Effect as of December 31, 1948, with Ancillaries and IndexDivision of the Federal Register, the National Archives, 1998 Special edition of the Federal Register, containing a codification of documents of general applicability and future effect ... with ancillaries. |
No grāmatas satura
1.–5. rezultāts no 100.
163. lappuse
... Removal of a drug product from the list . ( a ) FDA will remove a previously ap- proved new drug product from the list for the period stated when : ( 1 ) The agency withdraws or suspends approval of a new drug application or an ...
... Removal of a drug product from the list . ( a ) FDA will remove a previously ap- proved new drug product from the list for the period stated when : ( 1 ) The agency withdraws or suspends approval of a new drug application or an ...
261. lappuse
... Remove petrola- tum or greasy ointment before using this product because they interfere with the ability of this product to ad- here properly to the skin area . ' ( 9 ) For products for external use only containing resorcinol identified ...
... Remove petrola- tum or greasy ointment before using this product because they interfere with the ability of this product to ad- here properly to the skin area . ' ( 9 ) For products for external use only containing resorcinol identified ...
280. lappuse
... removal of common warts . The common wart is easily rec- ognized by the rough ' cauliflower - like ' appearance of ... remove plaster and discard . Repeat procedure every 24 hours as needed ( until wart is removed ) for up to 12 weeks ...
... removal of common warts . The common wart is easily rec- ognized by the rough ' cauliflower - like ' appearance of ... remove plaster and discard . Repeat procedure every 24 hours as needed ( until wart is removed ) for up to 12 weeks ...
281. lappuse
... removal of corns and cal- luses . " ( 2 ) In addition to the information identified in paragraph ( b ) ( 1 ) of this ... remove the medicated plaster . Repeat this procedure every 48 hours as needed for up to 14 days ( until corn / cal ...
... removal of corns and cal- luses . " ( 2 ) In addition to the information identified in paragraph ( b ) ( 1 ) of this ... remove the medicated plaster . Repeat this procedure every 48 hours as needed for up to 14 days ( until corn / cal ...
283. lappuse
... removing comb may be used to help remove dead lice or their eggs ( nits ) from hair . A second treat- ment must be done in 7 to 10 days to kill any newly hatched lice . " ( 3 ) For products formulated for use as a shampoo . “ Apply to ...
... removing comb may be used to help remove dead lice or their eggs ( nits ) from hair . A second treat- ment must be done in 7 to 10 days to kill any newly hatched lice . " ( 3 ) For products formulated for use as a shampoo . “ Apply to ...
Saturs
279 | |
285 | |
290 | |
299 | |
310 | |
331 | |
339 | |
340 | |
223 | |
236 | |
238 | |
239 | |
240 | |
256 | |
257 | |
262 | |
263 | |
265 | |
270 | |
275 | |
351 | |
483 | |
588 | |
593 | |
696 | |
699 | |
761 | |
826 | |
865 | |
890 | |
911 | |
949 | |
Citi izdevumi - Skatīt visu
Bieži izmantoti vārdi un frāzes
abbre abbreviated application abbreviated new drug acid active ingredient adverse drug experience agency amended antibiotic application or abbreviated bacitracin bioavailability bioequivalence cation Center for Drug certification chapter clinical hold clinical investigation conducted control number copy Cosmetic Act digoxin dosage form dose Drug Administration drug application Drug Evaluation drug prod drug product Drug products containing drug substance Evaluation and Research Federal Food Food and Drug graph gredients hearing hydrochloride identified information requirements ap insulin intended inves investigational new drug labeling manufacturer marketing meet ment milligrams milliliters misbranded neomycin notice oral dosage orphan drug OTC drug product package paragraph percent person plication polymyxin proposed protocol recognized as safe reference listed drug request safe and effective safety section 502 Sodium sponsor statement submission Subpart sulfate tained tigational tion tive treatment treatment IND vestigational viated warning